Cash flow LanZhou Foci Pharmaceutical Co.,Ltd.

Equities

002644

CNE1000019W4

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2024-09-11			5-day change	1st Jan Change
6.380 ^CNY	-1.39%		-2.74%	-34.56%

08-26	LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
08-15	LanZhou Foci Pharmaceutical Co.,Ltd. Announces Board Appointments	CI

46658f87d.KKeDa7iUipX4C9fwNiubrddM63X3S_2OAZmrZYXnuu8.bs_mUuvX4P-8eYiVR3nynq98kka5Gszna6v0I-axyY1g78FS4NXF5cFF7w

Published financial data: LANZHOU FOCI PHARMACEUTICAL CO.,LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	625M	660M	809M	1.02B	1.16B
Other Revenues, Total	3.83M	8.09M	8.25M	1.5M	5.45M
Total Revenues	629M	668M	818M	1.02B	1.16B
Cost of Goods Sold, Total	456M	497M	597M	734M	804M
Gross Profit	173M	171M	221M	285M	359M
Selling General & Admin Expenses, Total	148M	120M	131M	167M	237M
Provision for Bad Debts	8.42M	3.12M	9.97M	18.21M	15.07M
R&D Expenses	20.65M	15.38M	19.36M	23.56M	30.93M
Other Operating Expenses	13.14M	13.82M	14.82M	14.47M	13.32M
Other Operating Expenses, Total	190M	152M	175M	223M	296M
Operating Income	-16.44M	18.94M	45.65M	61.73M	62.9M
Interest Expense, Total	-1.12M	-1.28M	-946K	-678K	-1.24M
Interest And Investment Income	18.84M	12.82M	10.2M	7.48M	5.37M
Net Interest Expenses	17.72M	11.54M	9.26M	6.8M	4.13M
Currency Exchange Gains (Loss)	-17.33K	-366K	-329K	2.15M	1.08M
Other Non Operating Income (Expenses)	-42.03K	-108K	-1.22M	-5.63M	202K
EBT, Excl. Unusual Items	1.22M	30.01M	53.36M	65.05M	68.31M
Gain (Loss) On Sale Of Investments	-	-4.05M	-849K	-1.3M	-4.49M
Gain (Loss) On Sale Of Assets	67.54K	70.59M	27.18M	704	-
Asset Writedown	16K	154K	-374K	-202K	-392
Legal Settlements	-429K	-	10.92K	-	-
Other Unusual Items	82.58M	38.48M	31.48M	63.44M	17.83M
EBT, Incl. Unusual Items	83.45M	135M	111M	127M	81.64M
Income Tax Expense	8.79M	23.51M	17.3M	21.07M	13.52M
Earnings From Continuing Operations	74.67M	112M	93.52M	106M	68.12M
Net Income to Company	74.67M	112M	93.52M	106M	68.12M
Minority Interest	185K	306K	-259K	17.71K	-932K
Net Income - (IS)	74.85M	112M	93.26M	106M	67.19M
Net Income to Common Incl Extra Items	74.85M	112M	93.26M	106M	67.19M
Net Income to Common Excl. Extra Items	74.85M	112M	93.26M	106M	67.19M
Per Share Items
Net EPS - Basic	0.15	0.22	0.18	0.21	0.13
Basic EPS - Continuing Operations	0.15	0.22	0.18	0.21	0.13
Basic Weighted Average Shares Outstanding	511M	511M	511M	511M	511M
Net EPS - Diluted	0.15	0.22	0.18	0.21	0.13
Diluted EPS - Continuing Operations	0.15	0.22	0.18	0.21	0.13
Diluted Weighted Average Shares Outstanding	511M	511M	511M	511M	511M
Normalized Basic EPS	0	0.04	0.06	0.08	0.08
Normalized Diluted EPS	0	0.04	0.06	0.08	0.08
Dividend Per Share	0.06	0.12	0.01	0.05	0.03
Payout Ratio	8.87	27.36	65.88	4.82	41.59
Supplemental Items
EBITDA	36.36M	57.63M	93.58M	111M	114M
EBITA	-14.25M	20.9M	48.14M	64.85M	66.22M
EBIT	-16.44M	18.94M	45.65M	61.73M	62.9M
EBITDAR	39.51M	59.9M	96.82M	113M	118M
Total Revenues (As Reported)	629M	668M	-	1.02B	1.16B
Effective Tax Rate - (Ratio)	10.53	17.39	15.61	16.59	16.56
Total Current Taxes	50.36M	21.47M	17.12M	20.1M	13.3M
Total Deferred Taxes	-41.57M	2.04M	172K	967K	222K
Normalized Net Income	945K	19.06M	33.09M	40.68M	41.76M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	1.12M	-	-	-	-
Non-Cash Pension Expense	-	181K	313K	-	-
Supplemental Operating Expense Items
Advertising Expense	33.34M	22.32M	15.73M	21.09M	37.86M
Marketing Expenses	21.52M	15.22M	13.78M	22.31M	42.47M
Selling and Marketing Expenses	90.6M	70.6M	79.82M	103M	153M
General and Administrative Expenses	56.31M	46.73M	48.2M	61.39M	81.5M
Research And Development Expense From Footnotes	20.65M	15.38M	19.36M	23.56M	30.93M
Net Rental Expense, Total	3.15M	2.27M	3.25M	2.77M	4.1M
Imputed Operating Lease Interest Expense	276K	238K	290K	243K	752K
Imputed Operating Lease Depreciation	2.87M	2.03M	2.96M	2.52M	3.35M
Maintenance & Repair Expenses, Total	468K	788K	1.78M	928K	1.27M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	435M	420M	383M	396M	406M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	-	32.08M	-	2M	-
Total Cash And Short Term Investments	435M	452M	383M	398M	406M
Accounts Receivable, Total	251M	313M	345M	441M	383M
Other Receivables	17.66M	4.58M	1.05M	62.81M	42.64M
Total Receivables	268M	318M	346M	503M	425M
Inventory	287M	258M	259M	350M	370M
Other Current Assets, Total	46.43M	25.89M	46.67M	38.82M	37.82M
Total Current Assets	1.04B	1.05B	1.03B	1.29B	1.24B
Gross Property Plant And Equipment	1.03B	1.05B	1.25B	1.27B	1.31B
Accumulated Depreciation	-56.41M	-93.13M	-157M	-202M	-252M
Net Property Plant And Equipment	972M	956M	1.09B	1.07B	1.06B
Long-term Investments	77.28M	73.6M	71.65M	68.67M	64.1M
Goodwill	4.47M	4.47M	4.47M	4.47M	9.01M
Other Intangibles, Total	75.83M	74.01M	71.96M	76.79M	79.55M
Deferred Tax Assets Long-Term	46.53M	44.48M	51.11M	52.36M	53.65M
Deferred Charges Long-Term	401K	272K	894K	6M	7.65M
Other Long-Term Assets, Total	102M	59.77M	25.76M	20.41M	13.43M
Total Assets	2.31B	2.27B	2.35B	2.59B	2.53B
Liabilities
Accounts Payable, Total	335M	222M	214M	311M	310M
Accrued Expenses, Total	3.12M	9.98M	9.9M	26.85M	11.46M
Short-term Borrowings	-	19.62M	-	-	10M
Current Portion of Long-Term Debt	14.52M	14.36M	14.2M	13.4M	13.89M
Current Portion of Leases	-	-	500K	439K	799K
Current Income Taxes Payable	42.33M	42.2M	44.26M	44.58M	27.42M
Unearned Revenue Current, Total	13.42M	9.1M	35.91M	94.75M	47.02M
Other Current Liabilities	32.71M	22.03M	55.78M	39.43M	46.74M
Total Current Liabilities	441M	339M	375M	530M	468M
Long-Term Debt	79.97M	66.55M	53.14M	40.37M	26.6M
Long-Term Leases	-	-	807K	531K	1.35M
Unearned Revenue Non Current	281M	265M	295M	278M	261M
Deferred Tax Liability Non Current	879K	875K	847K	3.06M	3.07M
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	803M	671M	725M	853M	760M
Common Stock, Total	511M	511M	511M	511M	511M
Additional Paid In Capital	343M	343M	344M	344M	337M
Retained Earnings	655M	736M	759M	860M	896M
Comprehensive Income and Other	1.8M	1.62M	1.62M	1.6M	1.21M
Total Common Equity	1.51B	1.59B	1.61B	1.72B	1.75B
Minority Interest	2.02M	5.01M	12.92M	18.58M	23.06M
Total Equity	1.51B	1.6B	1.63B	1.73B	1.77B
Total Liabilities And Equity	2.31B	2.27B	2.35B	2.59B	2.53B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	511M	511M	511M	511M	511M
ECS Total Common Shares Outstanding	511M	511M	511M	511M	511M
Book Value / Share	2.96	3.12	3.16	3.36	3.42
Tangible Book Value	1.43B	1.51B	1.54B	1.63B	1.66B
Tangible Book Value Per Share	2.8	2.96	3.01	3.2	3.24
Total Debt	94.49M	101M	68.65M	54.74M	52.63M
Net Debt	-340M	-352M	-315M	-344M	-353M
Debt Equivalent Oper. Leases	25.19M	18.17M	25.97M	22.14M	32.8M
Minority Interest, Total (Incl. Fin. Div)	2.02M	5.01M	12.92M	18.58M	23.06M
Equity Method Investments, Total	77.28M	73.6M	71.65M	68.67M	64.1M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	83.42M	70.81M	68.94M	73.76M	112M
Inventories - Work In Process, Total	57.38M	58.89M	72.39M	71.83M	70.73M
Inventories - Finished Goods, Total	137M	117M	118M	190M	178M
Inventories - Others	10.29M	11.86M	-	15.56M	11.69M
Buildings, Total	788M	792M	928M	934M	939M
Machinery, Total	240M	254M	318M	333M	366M
Full Time Employees	1.44K	1.33K	-	1.4K	1.35K
Accumulated Allowance for Doubtful Accounts (Supple)	16.14M	19.67M	29.64M	47.85M	64.36M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	74.85M	112M	93.26M	106M	67.19M
Depreciation & Amortization - CF	50.61M	36.73M	46.07M	46.43M	49.16M
Amortization of Goodwill and Intangible Assets - (CF)	2.19M	1.96M	2.49M	3.12M	3.32M
Depreciation & Amortization, Total	52.8M	38.69M	48.56M	49.54M	52.49M
Amortization of Deferred Charges, Total - (CF)	461K	7.62M	378K	3.65M	5.98M
(Gain) Loss From Sale Of Asset	-67.54K	-70.59M	-27.18M	-704	-
(Gain) Loss on Sale of Investments - (CF)	-2.57M	4.05M	769K	1.3M	4.49M
Asset Writedown & Restructuring Costs	-16K	-154K	454K	202K	392
Provision and Write-off of Bad Debts	8.42M	3.12M	9.97M	-	-
Other Operating Activities, Total	858K	1.16M	2.62M	787K	3.23M
Change In Accounts Receivable	-84.7M	-48.9M	-66.85M	-210M	59.5M
Change In Inventories	-45.07M	28.94M	-805K	-91.7M	-7.3M
Change In Accounts Payable	83.55M	-15.06M	-49.49M	189M	-135M
Change In Income Taxes	-	-	-28.22K	-	-
Change In Deferred Taxes	-40.69M	2.04M	200K	967K	222K
Change in Other Net Operating Assets	-	-	-	23.15M	14.64M
Cash from Operations	47.82M	62.89M	11.85M	72.37M	65.71M
Capital Expenditure	-93.15M	-123M	-32.81M	-41.51M	-22.47M
Sale of Property, Plant, and Equipment	1.91M	93.14M	41.3M	38K	3.1K
Cash Acquisitions	-9.74M	-	-	-	-21.46M
Investment in Marketable and Equity Securities, Total	42.5M	-32.94M	32.48M	-2.13M	8M
Other Investing Activities, Total	444K	493K	1.67M	750K	1.77M
Cash from Investing	-58.04M	-61.89M	42.65M	-42.85M	-34.16M
Short Term Debt Issued, Total	-	19.61M	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	25.66M
Total Debt Issued	-	19.61M	-	-	25.66M
Short Term Debt Repaid, Total	-	-14.54M	-35.27M	-	-
Long-Term Debt Repaid, Total	-17.31M	-	-	-14.21M	-21.45M
Total Debt Repaid	-17.31M	-14.54M	-35.27M	-14.21M	-21.45M
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-6.64M	-30.64M	-61.43M	-5.11M	-27.94M
Common & Preferred Stock Dividends Paid	-6.64M	-30.64M	-61.43M	-5.11M	-27.94M
Other Financing Activities, Total	3.34M	2.02M	3.3M	3.87M	-1.26M
Cash from Financing	-20.6M	-23.55M	-93.41M	-15.45M	-25M
Foreign Exchange Rate Adjustments	-78.65K	-79.58K	-208K	700K	674K
Net Change in Cash	-30.89M	-22.62M	-39.11M	14.77M	7.23M
Supplemental Items
Cash Interest Paid	-	1.28M	-	678K	-
Cash Income Tax Paid (Refund)	47.06M	59.6M	78.4M	67.84M	101M
Levered Free Cash Flow	-242M	-187M	-33.49M	-26.57M	60.54M
Unlevered Free Cash Flow	-241M	-186M	-32.9M	-26.14M	61.32M
Change In Net Working Capital	191M	122M	77.56M	76.41M	13.98M
Net Debt Issued / Repaid	-17.31M	5.07M	-35.27M	-14.21M	4.21M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-0.42	0.52	1.2	1.56	1.53
Return on Total Capital	-0.65	0.72	1.69	2.21	2.17
Return On Equity %	5.06	7.19	5.82	6.3	3.88
Return on Common Equity	5.07	7.22	5.83	6.36	3.88
Margin Analysis
Gross Profit Margin %	27.56	25.58	27.04	27.98	30.86
SG&A Margin	23.46	17.9	16.05	16.4	20.35
EBITDA Margin %	5.78	8.63	11.44	10.85	9.83
EBITA Margin %	-2.27	3.13	5.89	6.36	5.69
EBIT Margin %	-2.61	2.84	5.58	6.06	5.41
Income From Continuing Operations Margin %	11.87	16.72	11.44	10.39	5.86
Net Income Margin %	11.9	16.76	11.41	10.4	5.78
Net Avail. For Common Margin %	11.9	16.76	11.41	10.4	5.78
Normalized Net Income Margin	0.15	2.85	4.05	3.99	3.59
Levered Free Cash Flow Margin	-38.49	-28.01	-4.1	-2.61	5.2
Unlevered Free Cash Flow Margin	-38.37	-27.89	-4.02	-2.56	5.27
Asset Turnover